Daniel J Müller (Mueller)

Sitert av

	Alle	Siden 2019
Sitater	20876	11503
h-indeks	78	48
i10-indeks	282	208

2400

1200

600

1800

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202468 125 134 129 161 222 317 369 332 430 477 521 606 769 820 1160 980 1388 1345 1576 1982 2096 2106 2340

Offentlig tilgang

Vis alle

165 artikler

70 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

James L KennedyProfessor of Psychiatry, Centre for Addiction and Mental Health, University of TorontoVerifisert e-postadresse på camh.ca
Arun Kumar TiwariCentre for Addiction and Mental Health, TorontoVerifisert e-postadresse på camh.ca
Clement C. ZaiUniversity of Toronto and Centre for Addiction and Mental HealthVerifisert e-postadresse på camh.ca
Jeffrey LiebermanProfessor of Psychiatry Columbia UniversityVerifisert e-postadresse på columbia.edu
Sidney H. KennedyProfessor of Psychiatry, University of TorontoVerifisert e-postadresse på uhn.ca
Roumen V MilevProfessor of Psychiatry and Psychology, Queen's University, Providence Care, Kingston, On, CanadaVerifisert e-postadresse på queensu.ca
Raymond W. Lam, MD, FRCPC, FCAHSProfessor and BC Leadership Chair in Depression Research, University of British ColumbiaVerifisert e-postadresse på ubc.ca
Herbert Y. MeltzerNorthwestern UniversityVerifisert e-postadresse på northwestern.edu
Eva BrandlCharité Universitätsmedizin BerlinVerifisert e-postadresse på charite.de
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, MedicalVerifisert e-postadresse på zi-mannheim.de
Benicio N. Frey, MD, PhD, FRCPCDepartment of Psychiatry and Behavioural Neurosciences, McMaster UniversityVerifisert e-postadresse på mcmaster.ca
Victoria S. MarsheCenter for Translational and Computational Neuroimmunology, Columbia University Medical CenterVerifisert e-postadresse på cumc.columbia.edu
Rudolf UherDalhousie UniversityVerifisert e-postadresse på dal.ca
Sagar V. ParikhProfessor of Psychiatry, University of MichiganVerifisert e-postadresse på umich.edu
Teri E. KleinStanford UniversityVerifisert e-postadresse på stanford.edu
Gwyneth ZaiClinician Scientist, Neurogenetics Section, Molecular Brain Science Department, Mood and AnxietyVerifisert e-postadresse på camh.ca
Benoit MulsantDepartment of Psychiatry, University of TorontoVerifisert e-postadresse på utoronto.ca
Turecki, GustavoMcGill UniversityVerifisert e-postadresse på mcgill.ca
Chad BousmanUniversity of CalgaryVerifisert e-postadresse på ucalgary.ca
eric lenzeWallace and Lucille Renard Professor of Psychiatry, Washington University School of MedicineVerifisert e-postadresse på wustl.edu

Følg

Daniel J Müller (Mueller)

Professor, University of Toronto / Centre for Addiction and Mental Health

Verifisert e-postadresse på camh.ca - Startside

pharmacogenetics pharmacogenomics psychiatry psychopharmacology precision medicine


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological … SH Kennedy, RW Lam, RS McIntyre, SV Tourjman, V Bhat, P Blier, ... The Canadian Journal of Psychiatry 61 (9), 540-560, 2016	1229	2016
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake … JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ... Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015	1026	2015
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ... Clinical pharmacology and therapeutics 102 (1), 37, 2017	671	2017
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ... Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013	530	2013
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process KE Caudle, TE Klein, JM Hoffman, DJ Müller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209, 2014	459	2014
Molecular mechanisms of schizophrenia UE Lang, I Puls, DJ Müller, N Strutz-Seebohm, J Gallinat Cellular Physiology and Biochemistry 20 (6), 687-702, 2007	400	2007
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy KR Crews, AA Monte, R Huddart, KE Caudle, ED Kharasch, A Gaedigk, ... Clinical Pharmacology & Therapeutics 110 (4), 888-896, 2021	331	2021
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications TAP Lett, TJM Wallace, NI Chowdhury, AK Tiwari, JL Kennedy, DJ Müller Molecular Psychiatry 17 (3), 242-266, 2011	304	2011
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update EJ Phillips, C Sukasem, M Whirl‐Carrillo, DJ Müller, HM Dunnenberger, ... Clinical Pharmacology & Therapeutics 103 (4), 574-581, 2018	281	2018
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Carbamazepine Dosing SG Leckband, JR Kelsoe, HM Dunnenberger, AL George Jr, E Tran, ... Clinical Pharmacology & Therapeutics 94 (3), 324-328, 2013	270	2013
Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder TG Schulze, DJ Müller, H Krauss, H Scherk, S Ohlraun, YV Syagailo, ... American Journal of Medical Genetics 96 (6), 801-803, 2000	242	2000
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ... Frontiers in psychiatry 9, 622, 2018	216	2018
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug–induced weight gain AK Malhotra, CU Correll, NI Chowdhury, DJ Müller, PK Gregersen, ... Archives of general psychiatry 69 (9), 904-912, 2012	215	2012
Comprehensive allelotype and genetic analysis of 466 human nervous system tumors A von Deimling, R Fimmers, MC Schmidt, B Bender, F Fassbender, ... Journal of Neuropathology & Experimental Neurology 59 (6), 544-558, 2000	211	2000
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting LV Kalman, JAG Agúndez, ML Appell, JL Black, GC Bell, S Boukouvala, ... Clinical Pharmacology & Therapeutics 99 (2), 172-185, 2016	207	2016
An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Pharmacopsychiatry 55 (02), 73-86, 2022	205	2022
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy JT Brown, JR Bishop, K Sangkuhl, EL Nurmi, DJ Mueller, JC Dinh, ... Clinical Pharmacology & Therapeutics 106 (1), 94-102, 2019	201	2019
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes JP Lopez, LM Fiori, C Cruceanu, R Lin, B Labonte, HM Cates, EA Heller, ... Nature communications 8 (1), 15497, 2017	188	2017
Genetics of antipsychotic treatment emergent weight gain in schizophrenia DJ Müller, JL Kennedy Pharmacogenomics 7 (6), 863-887, 2006	185	2006
Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. V De Luca, AHC Wong, DJ Muller, GW Wong, RF Tyndale, JL Kennedy Neuropsychopharmacology 29 (8), 1522-1526, 2004	177	2004

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere